RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $259,089 | -95.2% | 15,589 | -94.6% | 0.00% | -100.0% |
Q2 2023 | $5,393,735 | -0.7% | 288,435 | -2.5% | 0.00% | 0.0% |
Q1 2023 | $5,429,655 | -4.2% | 295,894 | +3.4% | 0.00% | 0.0% |
Q4 2022 | $5,665,532 | -17.7% | 286,138 | +0.1% | 0.00% | -25.0% |
Q3 2022 | $6,880,000 | +30.4% | 285,966 | -1.1% | 0.00% | +33.3% |
Q2 2022 | $5,277,000 | -16.8% | 289,114 | +0.3% | 0.00% | 0.0% |
Q1 2022 | $6,341,000 | -44.6% | 288,336 | -7.5% | 0.00% | -40.0% |
Q4 2021 | $11,453,000 | +2389.8% | 311,831 | +2008.0% | 0.01% | – |
Q3 2021 | $460,000 | +13.6% | 14,793 | +16.1% | 0.00% | – |
Q2 2021 | $405,000 | -73.5% | 12,744 | -81.5% | 0.00% | -100.0% |
Q1 2021 | $1,531,000 | +225.7% | 68,957 | +189.9% | 0.00% | – |
Q4 2020 | $470,000 | +139.8% | 23,786 | +290.3% | 0.00% | – |
Q3 2020 | $196,000 | +21.0% | 6,094 | +9.6% | 0.00% | – |
Q2 2020 | $162,000 | +1520.0% | 5,560 | +1032.4% | 0.00% | – |
Q1 2020 | $10,000 | -28.6% | 491 | -5.8% | 0.00% | – |
Q4 2019 | $14,000 | – | 521 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $35,171,000 | 45.66% |
KPCB XV Associates, LLC | 1,297,063 | $28,522,000 | 36.91% |
Ponoi II Management, LLC | 145,401 | $3,197,000 | 7.10% |
Column Group LLC | 1,402,008 | $30,830,000 | 5.72% |
Euclidean Capital LLC | 432,900 | $9,519,000 | 5.53% |
AJU IB Investment Co., Ltd. | 99,503 | $2,188,000 | 3.38% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,088,321 | $23,932,000 | 2.49% |
Velan Capital Investment Management LP | 110,000 | $2,419,000 | 2.24% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $9,755,000 | 1.46% |
Perceptive Advisors | 2,799,962 | $61,571,000 | 1.23% |